Skip to main content

West Pharmaceutical Services, Inc.

corporate_fare Company Profile

West Pharmaceutical Services, Inc.

WST·NYSE·Industrial Applications And Services·CIK 0000105770

WEST PHARMACEUTICAL SERVICES INC is a leading global manufacturer specializing in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The company's offerings include primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, alongside contract manufacturing, analytical lab services, and integrated solutions. Its customer base comprises leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. The company operates through two global business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment provides elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. This segment's packaging products include stoppers and seals for injectable packaging systems, designed to ensure drug compatibility and stability while supporting operational efficiency. It also offers syringe and cartridge components, including custom solutions for injectable drug applications, and administration systems that enhance safe drug delivery through advanced reconstitution, mixing, and transfer technologies. The company also provides films, coatings, washing, vision inspection, and sterilization processes and services to improve product quality and mitigate contamination and compatibility risks. This segment's portfolio also features drug containment solutions such as vials, syringes, plungers, and cartridges, which offer high-quality alternatives to address glass incompatibility and cold storage challenges, reducing breakage risk. Additionally, it offers various self-injection devices for at-home delivery of injectable therapies.

West Pharmaceutical Services, Inc. (NYSE:WST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for WST at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • West Pharma Reports Strong Q4 & Full-Year 2025 Results, Issues Positive 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.07B
Net Income
$493.7M
Diluted EPS
$6.79
Op. Cash Flow
$754.8M
Free Cash Flow
$468.9M
Gross Profit
$1.1B
Operating Income
$584.9M
Cash & Equivalents
$791.3M
Total Debt
$202.8M
Debt / Equity
0.06×
Net Margin
16.1%
Shares Outstanding
72M sh
Source: 10-K · filed 2026-02-17 · accession 0000105770-26-000010
$390.3
52-week range · as of 2026-10-29 $223.83 – $438.27
Market cap
$27.19B
Volume
623.5K (0.9× avg)
3-mo avg 685.3K
Live data · 2026-11-22 12:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WST - Filings & News (Page 2)

WST
Feb 12, 2026, 7:21 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $261.02
Real-time Price: $390.30 info
Change: +$129.28 (+50%) info
Market Cap: $27.189B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets